Examination of Pregnant Women in Third Trimester by Ultrasound to Detect Any Congenital Anomalies

October 3, 2024 updated by: Mahmoud Mohamed Desouky, Sohag University

Second and Third Trimestric Scan Versus Second Trimestric Scan Alone in Detection of Congenital Fetal Anomalies

this study aims to help the physicians to evaluate the practice of routine Third trimestric fetal scan whether it should be routinely performed to all cases including those with low risk singleton pregnancies.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

The third-trimester ultrasound scan ,traditionally performed at 32-34weeks, can assess fetal viability , presentation, anatomy , growth, amniotic fluid volume, placental location and fetoplacental Doppler.

There are multiple other indications that can trigger a third-trimester scan, including antepartum bleeding , reduced fetal movements, preterm rupture of the membranes and suspected abnormalities of fetal growth based on physical examination. In addition, ultrasound may be used to guide other procedures in the third trimester, such as external cephalic version. However, as yet, there is no convincing evidence that routine universal third-trimester ultrasound examination in a low-risk population improves either perinatal or maternal outcome especially in low socioeconomic countries with limited resources

Study Type

Observational

Enrollment (Estimated)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

normal pregnancies attending outpatient clinic in Sohag university Hospital

Description

Inclusion Criteria:

  • Singleton healthy pregnancy at second and third trimesters of pregnancy.
  • Fetuses were considered normal based on second trimestric fetal scan in our feto-maternal unit

Exclusion Criteria:

  • Exclusion criteria were patients with multiple gestations, maternal medical complications as Preeclampsia, DM ,Cardiac or renal diseases , or fetal abnormalities

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
normal third trimestric scam
cases in which second and third trimestric scan show no additional benefit over second trimestric scan alone
Other: ultrasound evaluation
Ultrasound scan of fetus in second and third trimestrers
new finding in third trimestric scan
cases in which second and third trimestric scan show additional benefit over second trimestric scan alone
Other: ultrasound evaluation
Ultrasound scan of fetus in second and third trimestrers

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
newly discovered congenital anomaly at third trimester of pregnancy
Time Frame: from October 2024 to April 2025
assessing Additional benefit of 3rd Trimester scan in low risk pregnancies attending sohag university regarding detection pf fetal congenital anomalies
from October 2024 to April 2025

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sohag University

Investigators

  • Principal Investigator: Mahmoud desoky Desoky, sohag university , Department of obstetric and gynecology

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 1, 2024

Primary Completion (Estimated)

April 1, 2025

Study Completion (Estimated)

April 1, 2025

Study Registration Dates

First Submitted

September 29, 2024

First Submitted That Met QC Criteria

October 3, 2024

First Posted (Actual)

October 4, 2024

Study Record Updates

Last Update Posted (Actual)

October 4, 2024

Last Update Submitted That Met QC Criteria

October 3, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • soh -Med-24-09-16MS

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Congenital Anomaly

Clinical Trials on ultrasound evaluation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe